Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Furberg

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Preventive Medicine|January 1, 1991
Organizing multicenter trials: lessons from cardiovascular prevention trialsC D Furberg
Zeitschrift Fur Kardiologie|January 1, 1985
The Beta-blocker Heart Attack TrialC D Furberg
Journal of Internal Medicine|September 29, 2001
Developing an optimal approach to global drug safetyR Balkrishnan, C D Furberg
American Heart Journal|February 15, 2001
Procedures of data and safety monitoring committeesS Pocock, C D Furberg
Cardiovascular Drugs and Therapy|December 1, 1987
Effects of calcium channel blockers on survival after myocardial infarctionS Yusuf, C D Furberg
The American Journal of Cardiology|July 11, 1988
Effect of drug therapy on survival in chronic congestive heart failureC D Furberg, S Yusuf
The American Journal of Cardiology|October 1, 1991
Are we biased in our approach to treating elderly patients with heart disease?S Yusuf, C D Furberg
Cardiovascular Drugs and Therapy|July 20, 1999
Calcium antagonists and cancer: causation or association?M Pahor, C D Furberg
Circulation|August 1, 1991
Antiarrhythmics and VPD suppressionC D Furberg, S Yusuf
Drugs & Aging|September 18, 1998
Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studiesM Pahor, C D Furberg
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Preventive Medicine|January 1, 1991
Organizing multicenter trials: lessons from cardiovascular prevention trialsC D Furberg
Zeitschrift Fur Kardiologie|January 1, 1985
The Beta-blocker Heart Attack TrialC D Furberg
Journal of Internal Medicine|September 29, 2001
Developing an optimal approach to global drug safetyR Balkrishnan, C D Furberg
American Heart Journal|February 15, 2001
Procedures of data and safety monitoring committeesS Pocock, C D Furberg
Cardiovascular Drugs and Therapy|December 1, 1987
Effects of calcium channel blockers on survival after myocardial infarctionS Yusuf, C D Furberg
The American Journal of Cardiology|July 11, 1988
Effect of drug therapy on survival in chronic congestive heart failureC D Furberg, S Yusuf
The American Journal of Cardiology|October 1, 1991
Are we biased in our approach to treating elderly patients with heart disease?S Yusuf, C D Furberg
Cardiovascular Drugs and Therapy|July 20, 1999
Calcium antagonists and cancer: causation or association?M Pahor, C D Furberg
Circulation|August 1, 1991
Antiarrhythmics and VPD suppressionC D Furberg, S Yusuf
Drugs & Aging|September 18, 1998
Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studiesM Pahor, C D Furberg
Pageof 21